Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using AS01 Adjuvant to Improve Immune Response in Older Adults Through Trained Immunity

NCT07527247 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT07527247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07527247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using AS01 Adjuvant to Improve Immune Response in Older Adults Through Trained Immunity
Lead sponsor
Singapore General Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
November 6, 2025
Completion date
February 28, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult, immune system responses and trained immunity after as01 administration